NCT05391581 (GA-17) is a NA clinical trial of GIPR antagonist / study tool in Blood Flow, sponsored by University of Copenhagen.

Who is sponsoring NCT05391581?

NCT05391581 is sponsored by University of Copenhagen.

What drugs are being tested in NCT05391581?

Interventions in NCT05391581: GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo.

What condition does NCT05391581 study?

NCT05391581 studies Blood Flow.

Is NCT05391581 still recruiting?

NCT05391581 is currently completed. Last updated 26 December 2023.

Last reviewed 2023-12-26 · How we verify

NCT05391581: GA-17

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism

Completed NA Last updated 26 December 2023

What this trial tests

NA trial testing GIPR antagonist / study tool in Blood Flow in 10 participants. Completed in 7 February 2023.

Timeline

13 January 2022

Primary endpoint
7 February 2023

7 February 2023

Quick facts

Lead sponsor	University of Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	10
Start date	13 January 2022
Primary completion	7 February 2023
Estimated completion	7 February 2023
Sites	1 location across Denmark

Drugs / interventions tested

GIPR antagonist / study tool
GLP-2R antagonist / study tool
Placebo

Conditions studied

Blood Flow — all drugs for Blood Flow →

Sponsor

University of Copenhagen

Who can join

Adults 20 to 70, male only, with Blood Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will describe the mechanisms of action and the relative contributions of GIP and GLP-2 to changes in gastrointestinal blood flow induced by oral glucose, exogenous GIP and GLP-2 infusions, and endogenous GIP and GLP-2 with the use of two novel receptor antagonists GIP(3-30)NH2 and GLP-2(3-33) in healthy individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of GIPR antagonist / study tool

Trials testing the same drug.

NCT06426823 — The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes · NA · completed

Other recruiting trials for Blood Flow

Currently open trials in the same condition.

NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
NCT06882733 — The Immediate Effect of Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Sympathetic Ganglion and Gastrocn · NA · recruiting
NCT06520982 — Early Neurovascular Adaptations in Aging Women · EARLY_PHASE1 · recruiting
NCT06238609 — Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome · NA · active not recruiting
NCT06192992 — Regional Blood Flow During Peripheral Heating · NA · recruiting

Other University of Copenhagen trials

Trials by the same sponsor.

NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
NCT07389421 — School Meals in Denmark · NA · not yet recruiting
NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05391581 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
Last refreshed: 26 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05391581.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing